Literature DB >> 6187504

Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease.

R K Mallya, B J Young, M B Pepys, T J Hamblin, B E Mace, E B Hamilton.   

Abstract

Anti-keratin antibodies (AKA) were detected in 68 out of 98 patients (69%) with classical or definite rheumatoid arthritis (RA). The intensity of the AKA reaction correlated significantly with articular index (AI), grip strength (GS), erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) concentration, serum amyloid A (SAA) protein concentration, the level of antibodies against single stranded DNA (ssDNA) and the IgM rheumatoid factor (RF) titre. A significantly higher number of patients with nodules and Sjögren's syndrome were AKA positive compared with patients without extra-articular features (EAFs) and the AKA titre was significantly greater in the former group. The mechanisms underlying appearance of AKA are not known but may relate to an as yet unidentified structural alteration of keratin in this disease or may just reflect the rheumatoid autoimmune diathesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187504      PMCID: PMC1536752     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  Studies on isolated keratin fractions from mammalian epidermis. II. Immunological and immuno-electrophoretic comparison of the fractions.

Authors:  F W Bauer
Journal:  Dermatologica       Date:  1972

3.  An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA.

Authors:  J L Klotz; R M Minami; R L Teplitz
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  Anti-keratin antibodies in rheumatoid arthritis.

Authors:  B J Young; R K Mallya; R D Leslie; C J Clark; T J Hamblin
Journal:  Br Med J       Date:  1979-07-14

5.  Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis.

Authors:  D L Scott; J P Delamere; L J Jones; K W Walton
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

6.  Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.

Authors:  R K Mallya; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

7.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

Authors:  M B Pepys; A C Dash; R E Markham; H C Thomas; B D Williams; A Petrie
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

8.  The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors:  R K Mallya; B E Mace
Journal:  Rheumatol Rehabil       Date:  1981-02-01
  8 in total
  12 in total

1.  Antikeratin antibody in rheumatoid and psoriatic arthritis.

Authors:  C Cooper; D W Cotton; S K Jones; M I Cawley; B J Young
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

2.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 3.  Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.

Authors:  Sylviane Muller; Marko Radic
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

4.  Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.

Authors:  L Vasiliauskiene; A Wiik; M Høier-Madsen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

5.  Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis.

Authors:  Nehir Samanci; Sebahat Ozdem; Halide Akbas; Derya Mutlu; Meral Gultekin; Mehmet Arman; Levent Donmez
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

6.  High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'.

Authors:  C Vincent; G Serre; F Lapeyre; B Fournié; C Ayrolles; A Fournié; J P Soleilhavoup
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

7.  Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.

Authors:  C Vincent; F de Keyser; C Masson-Bessière; M Sebbag; E M Veys; G Serre
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

8.  Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

Authors:  R M Hoet; A M Boerbooms; M Arends; D J Ruiter; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

9.  Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases.

Authors:  P Youinou; P Le Goff; C B Colaco; J Thivolet; D Tater; J Viac; M Shipley
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

10.  Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis.

Authors:  L Paimela; M Gripenberg; P Kurki; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.